Kinaset Therapeutics: Funding, Investors & Team (Oct 2026)
Kinaset Therapeutics is a biotechnology company that develops precision medicines targeting kinase-driven diseases through selective inhibition strategies aimed at improving therapeutic profiles and addressing unmet clinical needs. Its pipeline focuses on small molecule inhibitors designed to modulate specific signalling pathways implicated in inflammatory, immune-mediated, and proliferative disorders by targeting distinct kinase enzymes with tailored selectivity. The company combines medicinal chemistry, structure-based design, and translational research to optimize compounds for efficacy, safety, and pharmacokinetic properties that support clinical evaluation. Kinaset Therapeutics collaborates with research institutions and industry partners to advance its programs and validate mechanisms of action in relevant disease models. Its development efforts prioritize therapeutic candidates that may offer differentiated treatment options for conditions driven by dysregulated kinase activity.
Kinaset Therapeutics has raised $103M across 1 funding round on record, the most recent a Series B of $103M announced in Jan 2026.
That round is above the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Kinaset Therapeutics Company Profile and Key Stats
Latest funding round on record: Jan 2026.
Kinaset Therapeutics Funding Rounds
Kinaset Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Kinaset Therapeutics Funding Compared to Other Health Care Startups
Kinaset Therapeutics' latest round of $103M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Kinaset Therapeutics in Health Care and Boston
Companies Similar to Kinaset Therapeutics
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Kinaset Therapeutics Funding FAQs
What does Kinaset Therapeutics do?
Kinaset Therapeutics is a biotechnology company that develops precision medicines targeting kinase-driven diseases through selective inhibition strategies aimed at improving therapeutic profiles and addressing unmet clinical needs. Its pipeline focuses on small molecule inhibitors designed to modulate specific signalling pathways implicated in inflammatory, immune-mediated, and proliferative disorders by targeting distinct kinase enzymes with tailored selectivity. The company combines medicinal chemistry, structure-based design, and translational research to optimize compounds for efficacy, safety, and pharmacokinetic properties that support clinical evaluation. Kinaset Therapeutics collaborates with research institutions and industry partners to advance its programs and validate mechanisms of action in relevant disease models. Its development efforts prioritize therapeutic candidates that may offer differentiated treatment options for conditions driven by dysregulated kinase activity.
How much funding has Kinaset Therapeutics raised?
Kinaset Therapeutics has raised $103M across 1 round on record. The most recent is a Series B of $103M announced in Jan 2026.
When did Kinaset Therapeutics last raise funding?
Kinaset Therapeutics' most recent funding round on record is a Series B of $103M, announced in Jan 2026.
Who founded Kinaset Therapeutics?
FundedIQ lists Robert Clarke (Founder) at Kinaset Therapeutics.
Where is Kinaset Therapeutics headquartered?
Kinaset Therapeutics is based in Boston, Massachusetts, United States.
How many employees does Kinaset Therapeutics have?
Kinaset Therapeutics is in the 11-50 employee band.
How does Kinaset Therapeutics' funding compare to other Health Care startups?
Kinaset Therapeutics' latest round of $103M is above the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Kinaset Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kinaset Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.